# Gorman Rupp Co: financial statements, quarterly

GRC · NYSE · CIK 42682 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grc.md) · [Financials](/companies/grc/financials.md) · [Filings](/companies/grc/filings.md) · [Insiders](/companies/grc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [161 d](/filings/0001193125-26-084820.md) | [159](/filings/0000950170-25-059254.md) | [170](/filings/0000950170-25-099039.md) | [168](/filings/0001193125-25-251006.md) | [163 d](/filings/0001193125-26-084820.md) | [164](/filings/0001193125-26-180225.md) | [179](/filings/0001193125-26-317911.md) | [173](/filings/0001193125-26-431890.md) | [167 d](/filings/0001193125-26-084820.md) | [177](/filings/0001193125-26-180225.md) | [186](/filings/0001193125-26-317911.md) | [193](/filings/0001193125-26-431890.md) |
| Cost of revenue | $m | [110 d](/filings/0001193125-26-084820.md) | [111](/filings/0000950170-25-059254.md) | [115](/filings/0000950170-25-099039.md) | [116](/filings/0001193125-25-251006.md) | [114 d](/filings/0001193125-26-084820.md) | [114](/filings/0001193125-26-180225.md) | [123](/filings/0001193125-26-317911.md) | [122](/filings/0001193125-26-431890.md) | [114 d](/filings/0001193125-26-084820.md) | [119](/filings/0001193125-26-180225.md) | [125](/filings/0001193125-26-317911.md) | [129](/filings/0001193125-26-431890.md) |
| Gross profit | $m | [50.9 d](/filings/0001193125-26-084820.md) | [48.4](/filings/0000950170-25-059254.md) | [54.1](/filings/0000950170-25-099039.md) | [52.7](/filings/0001193125-25-251006.md) | [49.2 d](/filings/0001193125-26-084820.md) | [50.3](/filings/0001193125-26-180225.md) | [56.1](/filings/0001193125-26-317911.md) | [50.4](/filings/0001193125-26-431890.md) | [52.3 d](/filings/0001193125-26-084820.md) | [57.4](/filings/0001193125-26-180225.md) | [60.6](/filings/0001193125-26-317911.md) | [64.5](/filings/0001193125-26-431890.md) |
| Selling, general and administrative | $m | [26.0 d](/filings/0001193125-26-084820.md) | [24.9](/filings/0000950170-25-059254.md) | [24.9](/filings/0000950170-25-099039.md) | [25.7](/filings/0001193125-25-251006.md) | [25.0 d](/filings/0001193125-26-084820.md) | [25.1](/filings/0001193125-26-180225.md) | [26.0](/filings/0001193125-26-317911.md) | [25.9](/filings/0001193125-26-431890.md) | [24.4 d](/filings/0001193125-26-084820.md) | [26.8](/filings/0001193125-26-180225.md) | [27.1](/filings/0001193125-26-317911.md) | [27.5](/filings/0001193125-26-431890.md) |
| Operating income | $m | [21.8 d](/filings/0001193125-26-084820.md) | [20.4](/filings/0000950170-25-059254.md) | [26.0](/filings/0000950170-25-099039.md) | [23.9](/filings/0001193125-25-251006.md) | [21.1 d](/filings/0001193125-26-084820.md) | [22.1](/filings/0001193125-26-180225.md) | [26.9](/filings/0001193125-26-317911.md) | [21.5](/filings/0001193125-26-431890.md) | [24.8 d](/filings/0001193125-26-084820.md) | [27.5](/filings/0001193125-26-180225.md) | [30.4](/filings/0001193125-26-317911.md) | [33.9](/filings/0001193125-26-431890.md) |
| Interest expense | $m | [10.1 d](/filings/0001437749-24-005519.md) | [10.1](/filings/0001437749-24-013628.md) | [9.0](/filings/0001437749-24-023715.md) | [7.8](/filings/0001437749-24-032214.md) | [6.7 d](/filings/0001193125-26-084820.md) | [6.2](/filings/0001193125-26-180225.md) | [6.0](/filings/0001193125-26-317911.md) | [5.8](/filings/0001193125-26-431890.md) | [5.4 d](/filings/0001193125-26-084820.md) | [5.0](/filings/0001193125-26-180225.md) | [4.7](/filings/0001193125-26-317911.md) | [4.3](/filings/0001193125-26-431890.md) |
| Income tax | $m | [2.3 d](/filings/0001193125-26-084820.md) | [2.2](/filings/0000950170-25-059254.md) | [2.3](/filings/0000950170-25-099039.md) | [3.1](/filings/0001193125-25-251006.md) | [2.7 d](/filings/0001193125-26-084820.md) | [3.4](/filings/0001193125-26-180225.md) | [4.6](/filings/0001193125-26-317911.md) | [4.0](/filings/0001193125-26-431890.md) | [4.2 d](/filings/0001193125-26-084820.md) | [4.4](/filings/0001193125-26-180225.md) | [6.0](/filings/0001193125-26-317911.md) | [7.1](/filings/0001193125-26-431890.md) |
| Net income | $m | [9.0 d](/filings/0001193125-26-084820.md) | [7.9](/filings/0001193125-25-251006.md) | [8.3](/filings/0001193125-25-251006.md) | [12.9](/filings/0001193125-25-251006.md) | [11.0 d](/filings/0001193125-26-084820.md) | [12.1](/filings/0001193125-26-431890.md) | [15.8](/filings/0001193125-26-431890.md) | [11.3](/filings/0001193125-26-431890.md) | [13.7 d](/filings/0001193125-26-084820.md) | [17.8](/filings/0001193125-26-431890.md) | [19.4](/filings/0001193125-26-431890.md) | [22.7](/filings/0001193125-26-431890.md) |
| Diluted EPS | $ per share | not reported | [0.30](/filings/0000950170-25-059254.md) | [0.32](/filings/0000950170-25-099039.md) | [0.49](/filings/0001193125-25-251006.md) | not reported | [0.46](/filings/0001193125-26-180225.md) | [0.60](/filings/0001193125-26-317911.md) | [0.43](/filings/0001193125-26-431890.md) | not reported | [0.68](/filings/0001193125-26-180225.md) | [0.74](/filings/0001193125-26-317911.md) | [0.86](/filings/0001193125-26-431890.md) |
| Basic EPS | $ per share | not reported | [0.30](/filings/0000950170-25-059254.md) | [0.32](/filings/0000950170-25-099039.md) | [0.49](/filings/0001193125-25-251006.md) | not reported | [0.46](/filings/0001193125-26-180225.md) | [0.60](/filings/0001193125-26-317911.md) | [0.43](/filings/0001193125-26-431890.md) | not reported | [0.68](/filings/0001193125-26-180225.md) | [0.74](/filings/0001193125-26-317911.md) | [0.86](/filings/0001193125-26-431890.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.5](/filings/0001437749-25-005856.md) | [27.8](/filings/0001437749-24-013628.md) | [34.2](/filings/0001437749-24-023715.md) | [39.7](/filings/0001437749-24-032214.md) | [24.2](/filings/0001193125-26-084820.md) | [21.8](/filings/0000950170-25-059254.md) | [27.0](/filings/0000950170-25-099039.md) | [42.9](/filings/0001193125-25-251006.md) | [35.1](/filings/0001193125-26-431890.md) | [29.9](/filings/0001193125-26-180225.md) | [43.6](/filings/0001193125-26-317911.md) | [59.3](/filings/0001193125-26-431890.md) |
| Current assets | $m | [236](/filings/0001437749-25-005856.md) | [236](/filings/0001437749-24-013628.md) | [246](/filings/0001437749-24-023715.md) | [241](/filings/0001437749-24-032214.md) | [221](/filings/0001193125-26-084820.md) | [224](/filings/0000950170-25-059254.md) | [231](/filings/0000950170-25-099039.md) | [239](/filings/0001193125-25-251006.md) | [234](/filings/0001193125-26-431890.md) | [239](/filings/0001193125-26-180225.md) | [248](/filings/0001193125-26-317911.md) | [261](/filings/0001193125-26-431890.md) |
| Total assets | $m | [890](/filings/0001437749-25-005856.md) | [887](/filings/0001437749-24-013628.md) | [891](/filings/0001437749-24-023715.md) | [883](/filings/0001437749-24-032214.md) | [858](/filings/0001193125-26-084820.md) | [858](/filings/0000950170-25-059254.md) | [862](/filings/0000950170-25-099039.md) | [870](/filings/0001193125-25-251006.md) | [860](/filings/0001193125-26-431890.md) | [862](/filings/0001193125-26-180225.md) | [866](/filings/0001193125-26-317911.md) | [879](/filings/0001193125-26-431890.md) |
| Current liabilities | $m | [101](/filings/0001437749-25-005856.md) | [102](/filings/0001437749-24-013628.md) | [101](/filings/0001437749-24-023715.md) | [101](/filings/0001437749-24-032214.md) | [87.5](/filings/0001193125-26-084820.md) | [92.7](/filings/0000950170-25-059254.md) | [96.7](/filings/0000950170-25-099039.md) | [115](/filings/0001193125-25-251006.md) | [98.6](/filings/0001193125-26-431890.md) | [81.5](/filings/0001193125-26-180225.md) | [88.4](/filings/0001193125-26-317911.md) | [96.9](/filings/0001193125-26-431890.md) |
| Total liabilities | $m | [541](/filings/0001437749-25-005856.md) | [534](/filings/0001437749-24-013628.md) | [533](/filings/0001437749-24-023715.md) | [516](/filings/0001437749-24-032214.md) | [485](/filings/0001193125-26-084820.md) | [476](/filings/0000950170-25-059254.md) | [464](/filings/0000950170-25-099039.md) | [465](/filings/0001193125-25-251006.md) | [445](/filings/0001193125-26-431890.md) | [436](/filings/0001193125-26-180225.md) | [425](/filings/0001193125-26-317911.md) | [418](/filings/0001193125-26-431890.md) |
| Long-term debt | $m | [383](/filings/0001437749-25-005856.md) | [377](/filings/0001437749-24-013628.md) | [377](/filings/0001437749-24-023715.md) | [362](/filings/0001437749-24-032214.md) | [348](/filings/0001193125-26-084820.md) | [334](/filings/0000950170-25-059254.md) | [319](/filings/0000950170-25-099039.md) | [301](/filings/0001193125-25-251006.md) | [284](/filings/0001193125-26-431890.md) | [293](/filings/0001193125-26-180225.md) | [275](/filings/0001193125-26-317911.md) | [250](/filings/0001193125-26-431890.md) |
| Current portion of debt | $m | [21.9](/filings/0001437749-25-005856.md) | [24.1](/filings/0001437749-24-013628.md) | [18.5](/filings/0001437749-24-023715.md) | [18.5](/filings/0001437749-24-032214.md) | [18.5](/filings/0001193125-26-084820.md) | [18.5](/filings/0000950170-25-059254.md) | [18.5](/filings/0000950170-25-099039.md) | [20.8](/filings/0001193125-25-251006.md) | [23.1](/filings/0001193125-26-431890.md) | [0.0](/filings/0001193125-26-180225.md) | [0.0](/filings/0001193125-26-317911.md) | [0.0](/filings/0001193125-26-431890.md) |
| Shareholders' equity | $m | [349](/filings/0001193125-26-084820.md) | [354](/filings/0001193125-25-251006.md) | [359](/filings/0001193125-25-251006.md) | [367](/filings/0001193125-25-251006.md) | [374](/filings/0001193125-26-431890.md) | [382](/filings/0001193125-26-431890.md) | [398](/filings/0001193125-26-431890.md) | [405](/filings/0001193125-26-431890.md) | [415](/filings/0001193125-26-431890.md) | [426](/filings/0001193125-26-431890.md) | [441](/filings/0001193125-26-431890.md) | [461](/filings/0001193125-26-431890.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.6 d](/filings/0001193125-26-084820.md) | [10.7](/filings/0000950170-25-059254.md) | [22.7 d](/filings/0000950170-25-099039.md) | [27.2 d](/filings/0001193125-25-251006.md) | [9.3 d](/filings/0001193125-26-084820.md) | [21.1](/filings/0001193125-26-180225.md) | [27.8 d](/filings/0001193125-26-317911.md) | [42.3 d](/filings/0001193125-26-431890.md) | [15.0 d](/filings/0001193125-26-084820.md) | [22.0](/filings/0001193125-26-180225.md) | [40.5 d](/filings/0001193125-26-317911.md) | [52.4 d](/filings/0001193125-26-431890.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001193125-26-084820.md) | [3.9](/filings/0000950170-25-059254.md) | [3.2 d](/filings/0000950170-25-099039.md) | [3.2 d](/filings/0001193125-25-251006.md) | [4.0 d](/filings/0001193125-26-084820.md) | [3.0](/filings/0001193125-26-180225.md) | [3.0 d](/filings/0001193125-26-317911.md) | [6.6 d](/filings/0001193125-26-431890.md) | [4.8 d](/filings/0001193125-26-084820.md) | [4.3](/filings/0001193125-26-180225.md) | [3.6 d](/filings/0001193125-26-317911.md) | [6.8 d](/filings/0001193125-26-431890.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2012 (2012-09-30) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.0](/filings/0001193125-12-439835.md) | [21.0](/filings/0001193125-13-181900.md) | [21.0](/filings/0001193125-13-306425.md) | [26.2](/filings/0000950170-25-059254.md) | [26.2](/filings/0000950170-25-099039.md) | [26.2](/filings/0001193125-25-251006.md) | [26.2](/filings/0001193125-26-180225.md) | [26.3](/filings/0001193125-26-317911.md) | [26.3](/filings/0001193125-26-431890.md) | [26.3](/filings/0001193125-26-180225.md) | [26.4](/filings/0001193125-26-317911.md) | [26.4](/filings/0001193125-26-431890.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,410,243 at 2026-10-26, from the cover of the [10-Q filed 2026-10-26](/filings/0001193125-26-431890.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.